Abstract | INTRODUCTION: The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease. METHODS: The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease ( COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics. RESULTS: 133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/ PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients. Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care (<6%). 67% of all patients were seen by a specialist in pulmonary care in the last 36 months, but in less than 15% the vaccination status was evaluated. DISCUSSION: Use of and adherence for PPSV23 and influenza vaccinations is low in patients with COPD, AB and ILD in south east Germany.
|
Authors | Arno Mohr, Annelie Plentz, Anna Sieroslawski, Fabian Pezenburg, Michael Pfeifer, Bernd Salzberger, Florian Hitzenbichler |
Journal | Respiratory medicine
(Respir Med)
2020 Nov - Dec
Vol. 174
Pg. 106207
ISSN: 1532-3064 [Electronic] England |
PMID | 33152552
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- 13-valent pneumococcal vaccine
- 23-valent pneumococcal capsular polysaccharide vaccine
- Influenza Vaccines
- Pneumococcal Vaccines
|
Topics |
- Aged
- Asthma
- Female
- Germany
(epidemiology)
- Humans
- Influenza Vaccines
- Lung Diseases, Interstitial
- Male
- Middle Aged
- Patient Acceptance of Health Care
(statistics & numerical data)
- Patient Compliance
(statistics & numerical data)
- Pneumococcal Vaccines
- Pulmonary Disease, Chronic Obstructive
- Risk
- Risk Factors
- Surveys and Questionnaires
- Vaccination
(statistics & numerical data)
|